Masami Yamauchi

1.2k total citations
53 papers, 402 citations indexed

About

Masami Yamauchi is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Masami Yamauchi has authored 53 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 21 papers in Epidemiology and 19 papers in Oncology. Recurrent topics in Masami Yamauchi's work include Liver Disease Diagnosis and Treatment (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Hepatitis C virus research (9 papers). Masami Yamauchi is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Hepatitis C virus research (9 papers). Masami Yamauchi collaborates with scholars based in Japan and United States. Masami Yamauchi's co-authors include Kazuaki Chayama, Michio Imamura, Eisuke Murakami, Takashi Nakahara, Tomokazu Kawaoka, Hiroshi Aikata, Masataka Tsuge, Atsushi Ono, Shinsuke Uchikawa and Hatsue Fujino and has published in prestigious journals such as Scientific Reports, The Journal of Infectious Diseases and Annals of Oncology.

In The Last Decade

Masami Yamauchi

46 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masami Yamauchi Japan 12 187 131 108 102 99 53 402
Yuki Imaoka Japan 10 130 0.7× 167 1.3× 52 0.5× 178 1.7× 103 1.0× 87 415
Pascal Ananian France 8 157 0.8× 160 1.2× 100 0.9× 296 2.9× 114 1.2× 11 534
Takahide Yokoyama Japan 14 120 0.6× 192 1.5× 159 1.5× 329 3.2× 95 1.0× 36 502
Matteo Antonino Italy 11 178 1.0× 185 1.4× 112 1.0× 187 1.8× 137 1.4× 16 432
Wanli Wang China 9 112 0.6× 345 2.6× 102 0.9× 221 2.2× 107 1.1× 19 616
Tsuyoshi Notake Japan 11 99 0.5× 162 1.2× 98 0.9× 189 1.9× 86 0.9× 73 381
Tom Hugh Australia 13 285 1.5× 122 0.9× 171 1.6× 189 1.9× 101 1.0× 32 442
Suresh Maximin United States 10 75 0.4× 86 0.7× 58 0.5× 146 1.4× 92 0.9× 18 447
Yoshimichi Chuganji Japan 11 305 1.6× 67 0.5× 192 1.8× 95 0.9× 149 1.5× 31 518
Dai Manaka Japan 14 162 0.9× 313 2.4× 50 0.5× 238 2.3× 140 1.4× 70 541

Countries citing papers authored by Masami Yamauchi

Since Specialization
Citations

This map shows the geographic impact of Masami Yamauchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masami Yamauchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masami Yamauchi more than expected).

Fields of papers citing papers by Masami Yamauchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masami Yamauchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masami Yamauchi. The network helps show where Masami Yamauchi may publish in the future.

Co-authorship network of co-authors of Masami Yamauchi

This figure shows the co-authorship network connecting the top 25 collaborators of Masami Yamauchi. A scholar is included among the top collaborators of Masami Yamauchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masami Yamauchi. Masami Yamauchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ono, Atsushi, C. Nelson Hayes, Ryoichi Miura, et al.. (2025). Multiomics Analysis of Liver Molecular Dysregulation Leading to Nonviral-Related Hepatocellular Carcinoma Development. Journal of Proteome Research. 24(3). 1102–1117.
2.
Tanabe, Kazuaki, Yoichi Hamai, Masami Yamauchi, et al.. (2025). Changes in chemotherapy-induced cognitive impairment in gastrointestinal cancer survivors using multidomain assessments: a prospective cohort study. Journal of Cancer Survivorship.
3.
Fujii, Yasutoshi, Atsushi Ono, C. Nelson Hayes, et al.. (2024). Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma. Cancers. 16(7). 1328–1328. 3 indexed citations
4.
Namba, Masashi, et al.. (2023). Concurrent Mutations in <i>STK11</i> and <i>KEAP1</i> Cause Treatment Resistance in <i>KRAS</i> Wild-type Non-small-cell Lung Cancer. Internal Medicine. 62(20). 3001–3004. 4 indexed citations
5.
Kawaoka, Tomokazu, Shinsuke Uchikawa, Hatsue Fujino, et al.. (2023). Caroli's disease in two siblings. Kanzo. 64(2). 66–73.
6.
Fujii, Yasutoshi, Atsushi Ono, C. Nelson Hayes, et al.. (2021). Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib. Journal of Experimental & Clinical Cancer Research. 40(1). 215–215. 32 indexed citations
7.
Nakahara, Takashi, Masafumi Ono, Takumi Kawaguchi, et al.. (2021). Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease. Journal of Gastroenterology and Hepatology. 37(3). 592–599. 5 indexed citations
8.
9.
Ando, Yuwa, Masami Yamauchi, Yumi Kosaka, et al.. (2020). Complete response to pembrolizumab in advanced hepatocellular carcinoma with microsatellite instability. Clinical Journal of Gastroenterology. 13(5). 867–872. 16 indexed citations
10.
Yoshikawa, Yuki, Michio Imamura, Yumi Kosaka, et al.. (2020). A case with life-threatening secondary sclerosing cholangitis caused by nivolumab. Clinical Journal of Gastroenterology. 14(1). 283–287. 21 indexed citations
11.
Kodama, Kenichiro, Akira Hiramatsu, Yuwa Ando, et al.. (2020). Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 36(6). 1685–1693. 5 indexed citations
12.
Morio, Kei, Tomokazu Kawaoka, Hiroshi Aikata, et al.. (2020). Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection. European Journal of Radiology. 124. 108828–108828. 11 indexed citations
13.
Kodama, Kenichiro, Tomokazu Kawaoka, Shinsuke Uchikawa, et al.. (2019). Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib. Oncology. 97(2). 75–81. 32 indexed citations
14.
Ohya, Kazuki, Michio Imamura, Yuji Teraoka, et al.. (2019). Successful retreatment with 12 weeks of glecaprevir and pibrentasvir for a genotype 2a HCV-infected hemodialysis patient who failed to respond to 8 weeks of prior glecaprevir and pibrentasvir therapy. Clinical Journal of Gastroenterology. 13(2). 267–270. 3 indexed citations
15.
Suzuki, Nobuaki, Shoichi Hazama, Takeshi Nagasaka, et al.. (2019). Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study). International Journal of Clinical Oncology. 24(10). 1223–1230. 9 indexed citations
16.
Yamauchi, Masami, et al.. (2014). A Case of Gingival Metastasis from Rectal Cancer in Which Immunohistochemistry and PET-CT Were Useful for the Diagnostic Procedure. Case Reports in Oncology. 7(1). 246–251. 3 indexed citations
17.
Shinozaki, Katsunori, et al.. (2013). [Three cases of cancer-related pain for which oxycodone injection was efficacious].. PubMed. 40(1). 119–23. 1 indexed citations
18.
Yamauchi, Masami, Masaki Miyamoto, Mikiya Kitamoto, et al.. (2012). A case of severe septic arthritis and multiple metastases associated with Klebsiella pneumoniae liver abscess. Kanzo. 53(12). 839–845. 1 indexed citations
19.
Yamauchi, Masami, et al.. (2011). Bleomycin-induced pulmonary fibrosis after tumor lysis syndrome in a case of advanced yolk sac tumor treated with bleomycin, etoposide and cisplatin (BEP) chemotherapy. International Journal of Clinical Oncology. 17(5). 528–531. 12 indexed citations
20.
Yamauchi, Masami, et al.. (1983). [Adenocarcinoma adjoining to the gastric antrum and minute carcinoid--a case report].. PubMed. 29(11). 1356–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuki Imaoka Breakdown of academic impact, for papers by Pascal Ananian Breakdown of academic impact, for papers by Takahide Yokoyama Breakdown of academic impact, for papers by Matteo Antonino Breakdown of academic impact, for papers by Wanli Wang Breakdown of academic impact, for papers by Tsuyoshi Notake Breakdown of academic impact, for papers by Tom Hugh Breakdown of academic impact, for papers by Suresh Maximin Breakdown of academic impact, for papers by Yoshimichi Chuganji Breakdown of academic impact, for papers by Dai Manaka
Rankless by CCL
2026